Recently, multinational pharmaceutical companies are still setting off a wave
of executive departures.
Among them, including the R&D leaders and founders of many enterprises, have also ushered in new changes
.
For example, on December 15, Boehringer Ingelheim China announced that Dr.
Pavol Dobrocky will succeed Mr.
Felix Gutsche as President and CEO
of Boehringer Ingelheim Greater China (Chinese mainland, Hong Kong and Taiwan) on March 1, 2023.
According to the data, Dong Bowen joined Boehringer Ingelheim
in 1998.
Prior to his appointment in China, he was Head of Business and Branch in Slovakia, Vienna Centrozone, Russian Company, and Global Regional Integration Management Project Leader
.
On December 12, Roche announced an important personnel announcement, Roche CEO Bill Anderson has decided to step down on
December 31, 2022.
After 16 years at Roche, Anderson will officially bid farewell to the multinational giant
.
Meanwhile, the CEO position of Roche Pharmaceuticals will be temporarily taken over by Thomas Schinecker until a successor is in place
.
On December 5, Fresenius Group announced that Carla Kriwet will leave and current CFO Helen Giza has been appointed as the new CEO, who will also serve as CFO until a new successor is
appointed.
It is understood that this change of coach is the second executive change
of Fresenius Medical in the past 2 months.
In May this year, Rice Powell, the former CEO of Fresenius Medical, announced that he would retire
in 2023.
Since then, Fresenius Medical has announced that Carla Kriwet will become the CEO of Fresenius Medical in October
.
On November 10, the CEOs of Biogen and Seagen, who had been vacant for half a year, were finally determined
.
Former Sanofi CEO Weibach will join Biogen, and former Novartis CEO David R.
Epstein will take the helm of Seagen
.
Among them, Biogen announced the appointment of former Sanofi CEO Christopher Viehbacher as president and CEO and board member, effective
November 14.
Seagen announces the appointment of David R.
Epstein as Chief Executive Officer (CEO) and Board of Directors
.
Seagen also announced the appointment of Roger Dansey as president
of research and development.
Dansey has served as Seagen's chief medical officer since 2018, and in May 2022, he was appointed interim CEO
.
Of course, in addition to the continuous appointment of multinational pharmaceutical companies, many domestic pharmaceutical companies have also "changed coaches"
in recent times.
On December 10, Dongea Ejiao issued an announcement that due to job changes, Liu Yanfeng and Ren Ruzhuo applied to resign as vice presidents of the company
.
After his resignation, Liu Yanfeng will no longer hold any position in the company, and Ren Ruzhuo will still work in
the company.
On December 7, Antengene announced the appointment of Xiaojing Zhang as the company's Chief Medical Officer (CMO).
In this role, Xiaojing will be responsible for global clinical R&D strategy and medical team development, based in Shanghai and New Jersey.
.
.
On the whole, the reasons for the departure of domestic and foreign executives are mainly "personal reasons", followed by "job transfers"
.
From the perspective of the positions left by executives, in addition to frequent changes such as deputy general managers and vice presidents, there are not a few
executives who leave core technical personnel.
The industry believes that under the background of the current complex pharmaceutical environment and the increasing competition of innovative drugs, the talent flow of pharmaceutical companies will become more frequent in the future, and talents with professional capabilities and matching the current development of enterprises will be more and more welcomed
by enterprises.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
